Filter
3529
Filtered Results: 3529
Text search:
blood
testing
Featured
Recommendations
371
New Publications
1083
Language
Document type
No document type
2211
Guidelines
501
Studies & Reports
409
Manuals
158
Strategic & Response Plan
83
Training Material
63
Fact sheets
60
Situation Updates
22
Infographics
9
Brochures
6
Resource Platforms
3
Online Courses
2
App
1
Videos
1
Countries / Regions
India
269
Kenya
119
Global
99
Nigeria
94
South Africa
92
Liberia
89
Sierra Leone
86
Tanzania
82
Ethiopia
76
Nepal
76
Uganda
71
Malawi
65
Zambia
60
Rwanda
56
Ghana
53
Western and Central Europe
49
Bangladesh
46
Africa
46
Namibia
41
Philippines
37
Lesotho
36
Latin America and the Carribbean
35
Myanmar / Burma
34
Zimbabwe
33
Congo, Democratic Republic of
32
Cambodia
24
Ukraine
23
South–East Asia Region
23
Indonesia
20
Guinea
19
Senegal
19
Asia
19
West and Central Africa
18
Syria
17
Russia
17
Mozambique
16
Eastern Europe
16
East and Southern Africa
15
Haiti
14
Eswatini/ Swaziland
13
Brazil
13
Botswana
13
Burkina Faso
12
Pakistan
12
Eastern Europe and Central Asia
12
USA
10
South Sudan
9
Germany
9
Middle East and North Africa
9
Albania
9
Cameroon
8
Western Pacific Region
8
Mali
7
Afghanistan
7
Georgia
7
Venezuela
6
Tajikistan
6
Moldova
6
Benin
5
Peru
5
Angola
5
Southern Africa
5
Saudi Arabia
4
Somalia
4
Iraq
4
Lebanon
4
Thailand
4
Sudan
4
Central African Republic
4
Colombia
4
Mexico
4
Palestine
4
Armenia
4
Guinea-Bissau
3
China
3
North Macedonia
3
Bolivia
3
Yemen
3
Poland
3
Laos
3
Iran
3
United Kingdom
3
Côte d’Ivoire / Ivory Coast
2
Jordan
2
Chad
2
Gambia
2
Papua New Guinea
2
Argentina
2
Hungary
2
Ecuador
2
Libya
2
Madagascar
2
Sri Lanka
2
Chile
2
Paraguay
2
Bhutan
2
Timor Leste/ East Timor
2
Vietnam
2
North America
2
Portugal
2
Bosnia and Herzegovina
2
Morocco
1
Togo
1
Turkey
1
Egypt
1
Serbia
1
Burundi
1
Honduras
1
El Salvador
1
Greece
1
Other region
1
Djibouti
1
Mongolia
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Slovakia
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Jamaica
1
Japan
1
Maldives
1
Mauritius
1
Tunisia
1
Spain
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1518
Clinical Guidelines
409
Public Health
179
Women & Child Health
165
Capacity Building
89
Key Resources
89
Pharmacy & Technologies
75
Annual Report MEDBOX
1
Toolboxes
HIV
436
COVID-19
225
TB
192
Ebola
147
Rapid Response
134
AMR
121
Mental Health
118
Caregiver
97
NTDs
92
NCDs
87
Pharmacy
68
Zika
47
Refugee
43
Conflict
40
Planetary Health
28
Disability
21
Specific Hazards
20
Global Health Education
16
Cholera
14
Polio
11
Natural Hazards
10
Health Financing Toolbox
5
Social Ethics
4
The aim of this toolkit is to guide countries on how to best estimate their current burden of dengue by combining existing data from dengue surveillance systems with on-going research efforts to measure the community burden
of dengue.
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
Cholera which disproportionally impacts poor countries and the most vulnerable continues to affect at least 47 countries across the globe, resulting in an estimated 1.3 – 4 million cases, and 21,000 - 143,000 deaths per year worldwide. In Ethiopia, despite major improvements seen in the increasing...
This handbook is intended primarily for front-line health care providers who are likely to see children (among other clients) in their day-to-day practice. These may include general practitioners, nurses, midwives, gynaecologists,
paediatricians, mental health professionals, first responders and st...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Yaws is a disfiguring non-venereal disease caused by infection with the spirochaete. Treponema pallidum subspecies pertenue which is closely related to the causative agent of syphilis and those of the other endemic treponematoses, bejel and pinta. The disease is endemic in certain areas of the World...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta...
The objective of this concept note and the framework it outlines is the elimination of a group of CDs and the negative health effects they generate, which together create a tangible burden on affected individuals, their families and communities, and on health care systems throughout the Region. Thou...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage
to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ...
Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and
death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
